PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy.\', \'IRCCS-Fondazione Santa Lucia, Rome, Italy.\', \'Department of Human Neurosciences, Sapienza University of Rome, Rome, Italy.\', \'Department of Neurology, Fatebenefratelli Hospital, Isola Tiberina, Rome, Italy.\', \'Department of Dynamic and Clinical Psychology, and Health Studies, Sapienza University of Rome, Rome, Italy.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.2174/1570159X19666210517150418
?:doi
?:hasPublicationType
?:journal
  • Current neuropharmacology
is ?:pmid of
?:pmid
?:pmid
  • 33998993
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.21
?:rankingScore_hIndex
  • 53
is ?:relation_isRelatedTo_publication of
?:title
  • Off-label Uses of Selective Serotonin Reuptake Inhibitors (SSRIs).
?:type
?:year
  • 2022

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33998993>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33998993>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all